scispace - formally typeset
Open AccessJournal ArticleDOI

Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology

Reads0
Chats0
TLDR
Investigation of human primary airway epithelial cell cultures revealed that lumenal columnar cells, specifically ciliated epithelial cells, were targeted by RSV and that cultures became susceptible to infection as they differentiated into a ciliated phenotype, suggesting that RSV infection in the absence of an immune response can be tolerated for >3 months.
Abstract
Gene therapy for cystic fibrosis (CF) lung disease requires efficient gene transfer to airway epithelial cells after intralumenal delivery. Most gene transfer vectors so far tested have not provided the efficiency required. Although human respiratory syncytial virus (RSV), a common respiratory virus, is known to infect the respiratory epithelium, the mechanism of infection and the epithelial cell type targeted by RSV have not been determined. We have utilized human primary airway epithelial cell cultures that generate a well-differentiated pseudostratified mucociliary epithelium to investigate whether RSV infects airway epithelium via the lumenal (apical) surface. A recombinant RSV expressing green fluorescent protein (rgRSV) infected epithelial cell cultures with high gene transfer efficiency when applied to the apical surface but not after basolateral inoculation. Analyses of the cell types infected by RSV revealed that lumenal columnar cells, specifically ciliated epithelial cells, were targeted by RSV and that cultures became susceptible to infection as they differentiated into a ciliated phenotype. In addition to infection of ciliated cells via the apical membrane, RSV was shed exclusively from the apical surface and spread to neighboring ciliated cells by the motion of the cilial beat. Gross histological examination of cultures infected with RSV revealed no evidence of obvious cytopathology, suggesting that RSV infection in the absence of an immune response can be tolerated for >3 months. Therefore, rgRSV efficiently transduced the airway epithelium via the lumenal surface and specifically targeted ciliated airway epithelial cells. Since rgRSV appears to breach the lumenal barriers encountered by other gene transfer vectors in the airway, this virus may be a good candidate for the development of a gene transfer vector for CF lung disease.

read more

Citations
More filters
Journal ArticleDOI

Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology

TL;DR: In this review, the complete picture from epidemiology and virology to clinical impact and immunology is explored, finding that both the virus and the immune response contribute to damage to the lungs and subsequent disease, and therefore, any prevention or treatment needs to address both of these factors.
Journal ArticleDOI

Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

TL;DR: Human respiratory syncytial virus (RSV) was first isolated in 1956 from a laboratory chimpanzee with upper respiratory tract disease and was quickly determined to be of human origin and was shown to be the leading virus.
Journal ArticleDOI

The histopathology of fatal untreated human respiratory syncytial virus infection

TL;DR: Airway obstruction was a prominent feature in all cases attributed to epithelial and inflammatory cell debris mixed with fibrin, mucus, and edema, and compounded by compression from hyperplastic lymphoid follicles, which inform the understanding of RSV pathogenesis and may facilitate the development of new approaches for prevention and treatment.
Journal ArticleDOI

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

TL;DR: RSV is notable for a historic, tragic pediatric vaccine failure involving a formalin-inactivated virus preparation that was evaluated in the 1960s and that was poorly protective and paradoxically primed for enhanced RSV disease.
References
More filters
Journal ArticleDOI

Respiratory Syncytial Virus and Parainfluenza Virus

TL;DR: RSV and human parainfluenza virus types 1, 2, 3, and 4 have been known primarily as respiratory pathogens in young children but are now recognized as important pathogens in adults as well.
Journal ArticleDOI

Evidence for Periciliary Liquid Layer Depletion, Not Abnormal Ion Composition, in the Pathogenesis of Cystic Fibrosis Airways Disease

TL;DR: In this paper, two hypotheses, "hypotonic [low salt]/defensin" and "isotonic volume transport/mucus clearance", attempt to link defects in cystic fibrosis transmembrane conductance regulator-mediated ion transport to CF airways disease.
Journal Article

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airway disease

TL;DR: Data indicate that therapy for CF lung disease should not be directed at modulation of ionic composition, but rather at restoring volume on airway surfaces, as the failure to clear thickened mucus from airways surfaces likely initiates CF airways infection.
Journal ArticleDOI

Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development

TL;DR: It should be possible to introduce defined changes into infectious RSV using the M2(ORF1) protein, consistent with its recent identification as a transcription elongation factor and confirms its importance for RSV gene expression.
Journal ArticleDOI

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

TL;DR: The characterization of this negative-strand RNA virus identified a novel replication-competent deletion mutant lacking two of its three surface glycoproteins, which suggests that selective deletion of one or both of these RSV genes may provide an alternative or additive strategy for developing an optimally attenuated vaccine candidate.
Related Papers (5)